AI in Scientific Publications

The Role of AI in Transforming Scientific Publications

Scientific publishing is evolving rapidly with the advent of AI, transforming content creation, data visualization, and workflow management. While pharma publications demand rigorous accuracy and compliance, AI is making the journey from data to publication faster and more efficient and accelerating processes without compromising quality. However, it is vital to recognize at the outset that…...
Read More

Top Stories

NASSCOM GCC Summit 2025

What’s Next for Global Capability Centers )?

The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook

At the MAPS Americas 2025 conference in New Orleans, one of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
MAPS EMEA 2025

Amplifying the Patient Voice: Reflections from MAPS EMEA 2025

At this year’s MAPS EMEA 2025 Annual Meeting in London, the message was clear: the...
Graphical or Visual Abstracts

Graphical Abstracts – Communicating Complex Information Visually

Three years ago, we explored how visual abstracts revolutionize research communication by transforming dense scientific findings into...
NASSCOM GCC Summit 2025

What’s Next for Global Capability Centers (GCCs)? Cactus Life Sciences at the NASSCOM GCC Summit 2025

The theme for this year’s NASSCOM GCC Summit, “The Next GCC Frontier: Ambition, Agility, Ascent,”...
MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches

At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for Change in Writing, MedComms, and Field Strategy

Digital and AI were hot topics underpinning many of the conversations at the DIA’s Medical...
Rare diseases

Rare Diseases – An Evolving Medical Communications Landscape

A disease is considered rare when it affects fewer than 1 in 2,000 people. However...

Learn more ABOUT our company.